Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...

The stock of niche financial software company Vertex (NASDAQ: VERX) didn't get a very good start to the trading week at all.

Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.

Human cognition and AI cognition may never share a full axis. But independence does not imply isolation either. The future may not be convergence at all. The future may be a sort of “co-angulation,” ...

Get insights from Vertex Pharmaceuticals' Q3 2025 earnings call—revenue growth, pipeline milestones, and outlook for ALYFTREK, CASGEVY, and JOURNAVX.

'We wanted to do good but I didn't expect to be that good' - Unbeatable Paul Magnier celebrates five bunch sprints out of five at Tour of Guangxi 'The team will find another way' – Paul Magnier shows ...

At this time last season, entering the Jets’ seventh game, Will McDonald IV was already in the middle of a breakout year. He had already collected his seventh sack. Gang Green’s edge rusher reality — ...

The Liberal Democratic Party and Japan Innovation Party (JIP) agreed to form a coalition Monday, making it almost certain that LDP President Sanae Takaichi, who had struggled to find a new ally, will ...

On every game day this season, THN Fantasy will highlight players and goalies for fantasy managers to stream or roster for the rest of the season. The recommended players and goalies are usually ...

Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...

Something deadly might be wafting through the clouds shrouding Venus—a smelly, flammable gas called phosphine that annihilates life-forms reliant on oxygen for survival. Ironically, though, the ...